November 6th, 2026Tambiciclib Combo Shows Activity in Relapsed/Refractory Post-Venetoclax AMLInvestigators will present detailed findings from a phase 2 study assessing a tambiciclib-based regimen in patients with relapsed/refractory AML at ASH 2026.Read more